Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?

Kamasak T., TÜREDİ S., Serin H. M., MENTEŞE A., GÜNDÜZ A., ALVER A., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.1, ss.282-286, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1504-105
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.282-286
  • Anahtar Kelimeler: Ischemia-modified albumin, generalized clonic tonic, albumin, IMA/albumin, MYOCARDIAL-ISCHEMIA, ICTAL HYPOXEMIA, MARKER, BIOMARKERS, BINDING
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background/aim: In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.